Both body weight and BMI predicts improvement in symptom and functioning for patients with major depressive disorder.

[1]  Ching‐Yen Chen,et al.  Association of body mass index and depressive symptoms in a Chinese community population: results from the Health Promotion Knowledge, Attitudes, and Performance Survey in Taiwan. , 2011, Chang Gung medical journal.

[2]  S. Juo,et al.  Early Prediction of Fluoxetine Response for Han Chinese Inpatients With Major Depressive Disorder , 2011, Journal of clinical psychopharmacology.

[3]  Theo Stijnen,et al.  Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. , 2010, Archives of general psychiatry.

[4]  C. Wilcox,et al.  Body mass index and response to antidepressants in depressed research subjects. , 2009, The Journal of clinical psychiatry.

[5]  M. Rietschel,et al.  Body weight as a predictor of antidepressant efficacy in the GENDEP project. , 2009, Journal of affective disorders.

[6]  J. Sareen,et al.  Associations of obesity with psychiatric disorders and suicidal behaviors in a nationally representative sample. , 2009, Journal of psychosomatic research.

[7]  F. Holsboer,et al.  Overweight and Obesity Affect Treatment Response in Major Depression , 2007, Biological Psychiatry.

[8]  W. Brown,et al.  BMI, sex, and antidepressant response. , 2007, Journal of affective disorders.

[9]  R. Kessler,et al.  Association between obesity and psychiatric disorders in the US adult population. , 2006, Archives of general psychiatry.

[10]  S. Kennedy,et al.  Obesity in Bipolar Disorder and Major Depressive Disorder: Results from a National Community Health Survey on Mental Health and Well-Being , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[11]  Leona S. Aiken,et al.  Loss of Power in Logistic, Ordinal Logistic, and Probit Regression When an Outcome Variable Is Coarsely Categorized , 2006 .

[12]  N. Chu.  Prevalence of obesity in Taiwan , 2005, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[13]  A. Ferenczi,et al.  Obesity and Cortisol Status , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[14]  M. Fava,et al.  Obesity among outpatients with major depressive disorder. , 2005, The international journal of neuropsychopharmacology.

[15]  J. Ard,et al.  Prevalence of obesity in the United States , 2005, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[16]  R. Rosmond.  Obesity and depression: same disease, different names? , 2004, Medical hypotheses.

[17]  T. Insel,et al.  Depression and comorbid medical illness: the National Institute of Mental Health perspective , 2003, Biological Psychiatry.

[18]  M. Sullivan,et al.  Psychosocial functioning in the obese before and after weight reduction: construct validity and responsiveness of the Obesity-related Problems scale , 2003, International Journal of Obesity.

[19]  K. Sagduyu,et al.  Neuropsychopharmacology: The Fifth Generation of Progress , 2002 .

[20]  J. Mundt,et al.  The Work and Social Adjustment Scale: a simple measure of impairment in functioning. , 2002, The British journal of psychiatry : the journal of mental science.

[21]  David L Streiner,et al.  Breaking up is Hard to Do: The Heartbreak of Dichotomizing Continuous Data , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[22]  P. Björntorp,et al.  Central and peripheral glucocorticoid receptor function in abdominal obesity , 2002, Journal of endocrinological investigation.

[23]  Florian Holsboer,et al.  The Corticosteroid Receptor Hypothesis of Depression , 2000, Neuropsychopharmacology.

[24]  C. Beasley,et al.  Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose. , 2000, The Journal of clinical psychiatry.

[25]  P. Björntorp,et al.  Obesity and cortisol. , 2000, Nutrition.

[26]  J. Amsterdam,et al.  Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study. , 1997, The American journal of psychiatry.

[27]  D. Ragland,et al.  Dichotomizing Continuous Outcome Variables: Dependence of the Magnitude of Association and Statistical Power on the Cutpoint , 1992, Epidemiology.

[28]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[29]  F. J. Anscombe,et al.  Graphs in Statistical Analysis , 1973 .

[30]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[31]  G. Bray,et al.  Obesity related morbidity and mortality. , 2005, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

[32]  J. Markowitz,et al.  Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. , 2000, The American journal of psychiatry.

[33]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. , 1998, WMJ : official publication of the State Medical Society of Wisconsin.

[34]  Trevor R. Norman,et al.  Relationship between antidepressant response and plasma concentrations of fluoxetine and norfluoxetine , 1993, International clinical psychopharmacology.